Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 ,inter alia, to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2025 and recommendation of dividend, if any, for the financial year ended March 31, 2025.